Merge Healthcare, Inc. (MRGE) Tops Q2 EPS by 1c

Merge Healthcare, Inc. (NASDAQ: MRGE) reported Q2 adjusted EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $62.9 million versus the consensus estimate of $60.6 million.

For earnings history and earnings-related data on Merge Healthcare, Inc. (MRGE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
• Citi Reiterates Buy Rating on PG&E Corporation (PCG)
• MYT Netherlands Parent B.V. (MYTE) Announces Preliminary Third Quarter Results – Double-Digit Topline Growth Significantly Improved Profitability